Neurotransmission-associated proteins

Various embodiments of the invention provide human neurotransmission-associated proteins (NTRAN) and polynucleotides which identify and encode NTRAN. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KIMBERLY J. GIETZEN, APRIL J.A. HAFALIA, UYEN K. TRAN, JENNIFER A. GRIFFIN, VICKI S. ELLIOTT, BRENDAN M. DUGGAN, JOSEPH P. MARQUIS, SHANYA D. BECHA, HSIN-RU CHANG, JAYALAXMI RAMKUMAR, MARK L. BOROWSKY, CYNTHIA D. HONCHELL, BRIDGET A. WARREN, BROOKE M. EMERLING, JOANA X. LI, PEI JIN, REENA KHARE, HENRY YUE, Y. TOM TANG, SOO YEUN LEE, IAN J. FORSYTHE, PATRICIA M. LEHR-MASON, NARINDER K. CHAWLA, MARIAH R. BAUGHN, ERNESTINE A. LEE, AMY E. KABLE, SALLY LEE
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Various embodiments of the invention provide human neurotransmission-associated proteins (NTRAN) and polynucleotides which identify and encode NTRAN. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NTRAN.